BMB and SLU, Bonevolent AdhFix announcement
The study is a prospective case series at SLU's University Animal Hospital (Universitetsdjursjukhuset, UDS) in Uppsala, in privately owned dogs and cats that already require surgical treatment of a fracture, and the Product is used by SLU's veterinary surgeons within normal veterinary care. The study has ethical approval from the Uppsala animal ethics committee and is led at SLU by Professor Odd Höglund, professor of small animal surgery, in collaboration with BMB.
A central aim of the collaboration is to widen the base of indications for AdhFix: to understand which fracture types can benefit from the technique and where a shaped, light-cured composite fixation can add value compared with existing solutions.
"AdhFix is a promising addition to how we approach fracture fixation. This collaboration lets us evaluate, in real clinical cases and under full ethical oversight, which fractures benefit most from the technique and how it compares with the methods we use today,"
Professor Odd Höglund, professor of small animal surgery at SLU
In parallel with the research, BMB is making AdhFix available to veterinary clinics internationally.
"We are now making AdhFix available to veterinary clinics internationally, so surgeons can begin using the technique in appropriate cases today. Rigorous clinical research together with SLU and real-world availability go hand in hand, and both are central to how we grow responsibly,"
Michael Malkoch, CEO of BMB
Bonevolent AdhFix is a veterinary medical device for fracture fixation. It is a newer technique, and the SLU study is conducted under an approved clinical research protocol.
